Clinical Trials Logo

Filter by:
NCT ID: NCT05710120 Completed - Hepatitis C Clinical Trials

Hepatitis C Screening Alerts

Start date: January 16, 2023
Phase:
Study type: Observational

The objective of this study is to evaluate whether alerts that identify patients without hepatitis C infection to healthcare providers and clinic staff can increase the uptake of screening for hepatitis C. A period of time without alerts will be compared to a period of time with alerts.

NCT ID: NCT05710107 Completed - Postoperative Pain Clinical Trials

QL vs PENG for Analgesia After Hip Arthroplasty

Start date: February 7, 2023
Phase: N/A
Study type: Interventional

This study will consist of patients 18 years and older who are undergoing elective hip replacement with planned same day discharge. The patients will be randomized to receive a PENG+LFC or QL block prior to undergoing the surgery to help with postoperative pain control. The primary goal will be assessing postoperative opioid use during the first 72 hours after surgery. Secondary outcomes will include postoperative pain scores from, 0-72 hours. Additional outcomes consist of time to first ambulation, functional and mobility outcomes, PACU duration, patient satisfaction and opioid related side effects.

NCT ID: NCT05709873 Completed - Narcolepsy Clinical Trials

Narcolepsy Nightmare Study

Start date: February 22, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test two behavioral treatments for nightmares in adults with narcolepsy. The main questions it aims to answer are: - Is imagery rehearsal therapy (IRT) effective for narcolepsy-related nightmares? - Does adding targeted dream control (TDC) to IRT make it more effective? Participants will be randomized to one of two treatment groups and will be asked to: - Complete a daily log of sleep symptoms for up to 13 weeks. - Attend 7 sessions of treatment. - Complete questionnaires before and after treatment. - Go to the research lab in Evanston, IL to complete a sleep study during a daytime nap (Chicago area residents only).

NCT ID: NCT05709067 Completed - Clinical trials for Mental Health Wellness

Probiotics Effect on Mental Wellness

Moa
Start date: March 20, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effect of a probiotic strain on mental wellbeing in moderately stressed, healthy, adults in the general population. The main question it aims to answer is • what is the impact of probiotic consumption on overall mental wellbeing? Participants will consume one probiotic or placebo capsule per day, answer a set of questionnaire (at 3 time points) and wear a wearable device for the total duration of the study.

NCT ID: NCT05708963 Completed - Clinical trials for Cardiovascular Diseases

The U.K. Embryologist Fatigue Study

FUSE-UK
Start date: January 16, 2023
Phase:
Study type: Observational

The purpose of the study is to determine physical and mental health issues of U.K. embryologists related to their occupational characteristics, and how workplace fatigue and burnout may affect their quality of life, cynicism, interactions with patients, attention to detail, and lead to human error, the cause of the most severe IVF incidents that often make headlines and result in costly litigation. It will also correlate how the current manual workflows contribute to these health issues, and what measures can be taken to improve both working conditions and embryologists' health, and, therefore, improve patient care.

NCT ID: NCT05708573 Completed - Clinical trials for Healthy Participants

Potential Drug Interaction Between ALXN2040 and Rosuvastatin

Start date: February 1, 2023
Phase: Phase 1
Study type: Interventional

This study will assess the potential drug-drug interaction (DDI) between ALXN2040 and rosuvastatin.

NCT ID: NCT05708313 Completed - Clinical trials for Cardiovascular Diseases

Effects of 9-18 Weeks of Intensive Cardiac Rehabilitation After a Major Cardiovascular Event in Patients With CVD

AHH-ICR
Start date: September 20, 2019
Phase: N/A
Study type: Interventional

Implement an intensive cardiac rehabilitation program at Arkansas Heart Hospital (AHH) to find out if the AHH-ICR is equivalent to the CMS approved programs when it comes to results.

NCT ID: NCT05707390 Completed - Hepatic Impairment Clinical Trials

A Study of Mezigdomide in Healthy Participants and Participants With Hepatic Impairment

Start date: February 20, 2023
Phase: Phase 1
Study type: Interventional

The aim of this study is to measure the concentration levels of mezigdomide in the blood of participants with mild, moderate, and severe hepatic impairment, and in matched healthy control participants with normal hepatic function.

NCT ID: NCT05707156 Completed - Candidiasis Clinical Trials

Prospective Observational Study on the Incidence of Opportunistic Fungal Infections

Start date: July 5, 2023
Phase:
Study type: Observational

Corticosteroids exposure is a common risk factor for invasive fungal infections. Systemic corticosteroid therapy treats several medical conditions, including rejection in solid organ transplant recipients, malignancy, and autoimmune or inflammatory diseases. Corticosteroid exposure is a well-known risk factor for developing PJP. Still, it remains unclear how prior corticosteroid exposure influences the presentation, severity, and mortality of opportunistic fungal infections. The investigators aim to prospectively characterize the corticosteroid use as a dose response to inform risk of invasive fungal infections.

NCT ID: NCT05706935 Completed - Clinical trials for Respiratory Infection

MeMed BV® Test Evaluation in Adult Emergency Department Patients

Start date: February 6, 2023
Phase:
Study type: Observational

The goal of this observational study is to compare the results of a serum biomarker called the MeMed BV®, which is approved to help differentiate between bacterial and viral respiratory infections, to clinical diagnoses of adult emergency department patients presenting with recent fever and signs or symptoms of a respiratory infection. Active participation is completed during the emergency department visit and includes drawing blood, obtaining a sputum sample, and answering survey questions.